AI
RGEN icon

Axiom Investors’s Repligen RGEN Stock Holding History

Axiom Investors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,215
Closed -$3.6M – 145
2024
Q3 		$3.6M Sell
24,215
-16,679
-41% -$2.39M 0.03% 112
2024
Q2 		$5.16M Sell
40,894
-7,268
-15% -$1.14M 0.04% 106
2024
Q1 		$8.86M Buy
+48,162
New +$9.17M 0.08% 93
2023
Q2 		– Sell
-65,516
Closed -$11M – 144
2023
Q1 		$11M Sell
65,516
-31,520
-32% -$5.62M 0.18% 58
2022
Q4 		$16.4M Sell
97,036
-169,891
-64% -$30.8M 0.32% 55
2022
Q3 		$49.9M Buy
266,927
+217,052
+435% +$45.8M 1.05% 31
2022
Q2 		$8.1M Sell
49,875
-28,533
-36% -$4.51M 0.24% 58
2022
Q1 		$14.7M Sell
78,408
-15,111
-16% -$2.87M 0.35% 47
2021
Q4 		$24.8M Buy
93,519
+21,230
+29% +$5.72M 0.46% 50
2021
Q3 		$20.9M Buy
72,289
+51,596
+249% +$13.2M 0.34% 57
2021
Q2 		$4.13M Sell
20,693
-7,732
-27% -$1.5M 0.07% 97
2021
Q1 		$5.53M Sell
28,425
-19,950
-41% -$4.09M 0.1% 89
2020
Q4 		$9.27M Sell
48,375
-20,327
-30% -$3.7M 0.15% 66
2020
Q3 		$10.1M Buy
68,702
+13,775
+25% +$1.97M 0.16% 59
2020
Q2 		$6.79M Buy
54,927
+21,127
+63% +$2.49M 0.13% 61
2020
Q1 		$3.26M Sell
33,800
-5,565
-14% -$537K 0.08% 77
2019
Q4 		$3.64M Buy
39,365
+3,275
+9% +$275K 0.08% 89
2019
Q3 		$2.77M Buy
+36,090
New +$3.16M 0.07% 91
2015
Q1 		– Sell
-47,500
Closed -$941K – 158
2014
Q4 		$941K Buy
47,500
+4,138
+10% +$92.5K 0.02% 144
2014
Q3 		$863K Sell
43,362
-39,138
-47% -$824K 0.02% 136
2014
Q2 		$1.88M Sell
82,500
-28,836
-26% -$513K 0.04% 110
2014
Q1 		$1.43M Sell
111,336
-56,764
-34% -$814K 0.03% 121
2013
Q4 		$2.29M Buy
+168,100
New +$2.01M 0.06% 100

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Axiom Investors's RGEN Position: Q4 2024 in Review

Axiom Investors sold out of Repligen (RGEN) in Q4 2024, closing a stake of 24,215 shares — an estimated $3.6M sold.

Axiom Investors first reported a position in RGEN in Q4 2013 and held it in 23 quarters. The position peaked at $49.9M in Q3 2022. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

  • Axiom Investors reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
  • Axiom Investors sold 24,215 Repligen shares in Q4 2024, an estimated $3.6M.
  • Axiom Investors first reported a position in Repligen in Q4 2013 and held it in 23 quarters.
  • Axiom Investors's Repligen position peaked at $49.9M in Q3 2022.
  • 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on Axiom Investors's 13F filing for Q4 2024, filed 12 Feb 2025.